ATE487729T1 - Als antivirale mittel geeignete azacytosinderivate - Google Patents

Als antivirale mittel geeignete azacytosinderivate

Info

Publication number
ATE487729T1
ATE487729T1 AT06828083T AT06828083T ATE487729T1 AT E487729 T1 ATE487729 T1 AT E487729T1 AT 06828083 T AT06828083 T AT 06828083T AT 06828083 T AT06828083 T AT 06828083T AT E487729 T1 ATE487729 T1 AT E487729T1
Authority
AT
Austria
Prior art keywords
antiviral agents
azacytosine
azacytosine derivatives
derivatives used
provides
Prior art date
Application number
AT06828083T
Other languages
English (en)
Inventor
Antonin Holy
Marcela Krecmerov
Alois Piskala
Graciela Andrei
Robert Snoeck
Clercq Erik De
Johan Neyts
Lieve Naesens
Original Assignee
Leuven K U Res & Dev
Acad Of Science Czech Republic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0525033A external-priority patent/GB0525033D0/en
Priority claimed from GB0526668A external-priority patent/GB0526668D0/en
Priority claimed from GB0611440A external-priority patent/GB0611440D0/en
Application filed by Leuven K U Res & Dev, Acad Of Science Czech Republic filed Critical Leuven K U Res & Dev
Application granted granted Critical
Publication of ATE487729T1 publication Critical patent/ATE487729T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/657163Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms the ring phosphorus atom being bound to at least one carbon atom
    • C07F9/657181Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms the ring phosphorus atom being bound to at least one carbon atom the ring phosphorus atom and, at least, one ring oxygen atom being part of a (thio)phosphonic acid derivative
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6515Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having three nitrogen atoms as the only ring hetero atoms
    • C07F9/6518Five-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT06828083T 2005-12-08 2006-12-08 Als antivirale mittel geeignete azacytosinderivate ATE487729T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0525033A GB0525033D0 (en) 2005-12-08 2005-12-08 New Anti-viral Compounds
GB0526668A GB0526668D0 (en) 2005-12-09 2005-12-09 New anti-viral-compounds
GB0611440A GB0611440D0 (en) 2006-06-09 2006-06-09 New anti-viral molecules
PCT/BE2006/000130 WO2007065231A2 (en) 2005-12-08 2006-12-08 Azacytosine derivatives useful as antiviral agents

Publications (1)

Publication Number Publication Date
ATE487729T1 true ATE487729T1 (de) 2010-11-15

Family

ID=37989825

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06828083T ATE487729T1 (de) 2005-12-08 2006-12-08 Als antivirale mittel geeignete azacytosinderivate

Country Status (5)

Country Link
US (1) US8153787B2 (de)
EP (1) EP1966226B1 (de)
AT (1) ATE487729T1 (de)
DE (1) DE602006018195D1 (de)
WO (1) WO2007065231A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119060394A (zh) * 2024-08-09 2024-12-03 东莞市常青树运动用品有限公司 一种防雾镜片及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4347360A (en) * 1980-09-16 1982-08-31 Ens Bio Logicals Inc. Ring open nucleoside analogues
US20040138170A1 (en) 2002-03-06 2004-07-15 Montgomery John A. Nucleosides, preparation thereof and use as inhibitors of rna viral polymerases

Also Published As

Publication number Publication date
US8153787B2 (en) 2012-04-10
WO2007065231A3 (en) 2007-07-26
EP1966226B1 (de) 2010-11-10
DE602006018195D1 (de) 2010-12-23
WO2007065231A2 (en) 2007-06-14
EP1966226A2 (de) 2008-09-10
US20090005346A1 (en) 2009-01-01

Similar Documents

Publication Publication Date Title
WO2021262826A3 (en) 1'-cyano nucleoside analogs and uses thereof
EA200800178A1 (ru) Ингибиторы вируса гепатита с (hcv)
BRPI0418251C1 (pt) fosfonatos, monofosfonamidatos, bisfosfonamidatos, e, composição farmacêutica os compreendendo
ECSP045191A (es) "nuevos péptidos como inhibidores de la proteasa serina ns3 del virus de la hepatitis c"
NO20061479L (no) Anvendelse av modifiserte cyklosporiner for behandling av HCV-forstyrrelser
EA200901241A1 (ru) Соединения для лечения гепатита с
TW200716157A (en) Pharmaceutical formulations and methods of treatment using the same
ECSP066791A (es) Compuestos azufrados como inhibidores de la serina proteasa ns3 del virus de la hepatitis c
DK1377589T3 (da) Oxazolyl-pyrazolderivater som kinaseinhibitorer
CR8935A (es) Inhibidores de la arn polimerasa dependiente del arn del virus de la hepatitis c y composiciones
ECSP066794A (es) Nuevos compuestos como inhibidores de serina proteasa ns3 del virus de la hepatitis c
WO2004009020A3 (en) Pyrrolopyrimidine thionucleoside analogs as antivirals
WO2010034670A3 (en) Host cell kinases as targets for antiviral therapies against hcv infection
ECSP099685A (es) Compuestos de azufre como inhibidores de la serina proteasa ns3 del virus de la hepatitis c
WO2003105770A3 (en) Carbocyclic nucleoside analogs as rna-antivirals
BR122020006906B8 (pt) compostos e composições farmacêuticas antivirais
TW200630093A (en) Dose forms
ECSP066626A (es) Nuevos inhibidores de la ns3/ns4a serina proteasa del virus de la hepatitis c
WO2005123087A3 (en) C-purine nucleoside analogs as inhibitors of rna-dependent rna viral polymerase
ECSP10010618A (es) Análogos carba - nucleósidos para tratamiento antiviral
DK1556021T3 (da) Farmaceutiske sammensætninger omfattende flavonoider og menthol samt fremgangsmåder til behandling med brug af nævnte sammensætninger
NO20064584L (no) Tetrahydropyridoindolderivater
MY145074A (en) Thiazolidin-4-one derivatives
TW200510343A (en) Substituted dihydroquinazolines
NO20081628L (no) Benzodiazepiner som HCV-inhibitorer

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties